New Results
Location of CD39+ T cell sub-populations within tumours predict differential outcomes in non-small cell lung cancer
View ORCID ProfileLilian Koppensteiner, View ORCID ProfileLayla Mathieson, View ORCID ProfileSamuel Pattle, View ORCID ProfileDavid A Dorward, View ORCID ProfileRichard O’Connor, View ORCID ProfileAhsan Akram
doi: https://doi.org/10.1101/2022.09.29.509921
Lilian Koppensteiner
1Centre for Inflammation Research, Queen’s Medical Research Institute, University of Edinburgh, 47 Little France Crescent, Edinburgh BioQuarter, Edinburgh, United Kingdom, EH16 4TJ
2Translational Healthcare Technologies Group, Centre for Inflammation Research, Queen’s Medical Research Institute, University of Edinburgh, 47 Little France Crescent, Edinburgh BioQuarter, Edinburgh, United Kingdom, EH16 4TJ
Layla Mathieson
1Centre for Inflammation Research, Queen’s Medical Research Institute, University of Edinburgh, 47 Little France Crescent, Edinburgh BioQuarter, Edinburgh, United Kingdom, EH16 4TJ
2Translational Healthcare Technologies Group, Centre for Inflammation Research, Queen’s Medical Research Institute, University of Edinburgh, 47 Little France Crescent, Edinburgh BioQuarter, Edinburgh, United Kingdom, EH16 4TJ
Samuel Pattle
3Department of Pathology, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom
David A Dorward
1Centre for Inflammation Research, Queen’s Medical Research Institute, University of Edinburgh, 47 Little France Crescent, Edinburgh BioQuarter, Edinburgh, United Kingdom, EH16 4TJ
3Department of Pathology, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom
Richard O’Connor
1Centre for Inflammation Research, Queen’s Medical Research Institute, University of Edinburgh, 47 Little France Crescent, Edinburgh BioQuarter, Edinburgh, United Kingdom, EH16 4TJ
2Translational Healthcare Technologies Group, Centre for Inflammation Research, Queen’s Medical Research Institute, University of Edinburgh, 47 Little France Crescent, Edinburgh BioQuarter, Edinburgh, United Kingdom, EH16 4TJ
Ahsan Akram
1Centre for Inflammation Research, Queen’s Medical Research Institute, University of Edinburgh, 47 Little France Crescent, Edinburgh BioQuarter, Edinburgh, United Kingdom, EH16 4TJ
2Translational Healthcare Technologies Group, Centre for Inflammation Research, Queen’s Medical Research Institute, University of Edinburgh, 47 Little France Crescent, Edinburgh BioQuarter, Edinburgh, United Kingdom, EH16 4TJ
4Cancer Research UK Edinburgh Centre, Institute of Genetics & Molecular Medicine, The University of Edinburgh, Crewe Road South, Edinburgh, United Kingdom, EH4 2XR

Article usage
Posted September 30, 2022.
Location of CD39+ T cell sub-populations within tumours predict differential outcomes in non-small cell lung cancer
Lilian Koppensteiner, Layla Mathieson, Samuel Pattle, David A Dorward, Richard O’Connor, Ahsan Akram
bioRxiv 2022.09.29.509921; doi: https://doi.org/10.1101/2022.09.29.509921
Subject Area
Subject Areas
- Biochemistry (9109)
- Bioengineering (6753)
- Bioinformatics (23944)
- Biophysics (12103)
- Cancer Biology (9498)
- Cell Biology (13745)
- Clinical Trials (138)
- Developmental Biology (7617)
- Ecology (11664)
- Epidemiology (2066)
- Evolutionary Biology (15479)
- Genetics (10620)
- Genomics (14297)
- Immunology (9467)
- Microbiology (22800)
- Molecular Biology (9078)
- Neuroscience (48894)
- Paleontology (355)
- Pathology (1479)
- Pharmacology and Toxicology (2566)
- Physiology (3824)
- Plant Biology (8309)
- Synthetic Biology (2291)
- Systems Biology (6172)
- Zoology (1297)